Iris Dorbian

Domino Data Labs nabs $40 mln

San Francisco-based Domino Data Lab, a provider of an open data science platform, has secured $40 million in funding. Sequoia Capital and Coatue Management led the round.

Apexigen racks up $73 mln

Apexigen Inc, a biopharmaceutical company, has closed its Series B and Series C funding rounds at a total of $73 million. Decheng Capital led the $15 million Series B round while 3E Bioventures Capital, Virtus Inspire Ventures and SV Tech Ventures led the $58 million Series C round.

SQZ Biotechnologies attracts $72 mln Series C

Massachusetts-based SQZ Biotechnologies, a cell therapy company, has raised $72 million in Series C financing. The investors included Everblue, Illumina Ventures, Invus, Orient Life, Viva Ventures Biotech Group, Bridger Healthcare Partners, Global Health Science Fund, GV, JDRF T1D Fund, NanoDimension and Polaris.

Ambys Medicines fetches $60 mln Series A

Redwood City, California-based Ambys Medicines, a developer of new medicines patients suffering from chronic liver diseases, has launched with $60 million in Series A financing. The investors were Third Rock Ventures and Takeda.

Hinge Health picks up $26 mln Series B

Hinge Health has secured $26 million in Series B funding, according to a post by CEO and co-founder Daniel Perez. Insight Venture Partners led the round with participation from Atomico. San Francisco-based Hinge Health is a provider of digital care for chronic musculoskeletal conditions.

Root AI grabs $2.3 mln

Root AI, an AI-powered robotics company focused on "revolutionizing" indoor farming, has raised $2.3 million in funding, according to a blog post. First Round led the round with participation from other investors that included Accomplice, Schematic Ventures, Liquid2 Ventures and Half Court Ventures.

German tax startup Taxfix lands $13 mln Series A

Berlin-based tax startup Taxfix has raised $13 million in Series A funding. The lead investors were N26 and Valar Ventures. Other participants in the round were Creandum and Redalpine.

Frazier hires EIR and senior associate

Frazier Healthcare Partners has named Dr. Tracy Saxton as an entrepreneur-in-residence and Vanessa Bhark as a senior associate. Saxton is the founder and CEO of Aucupo Biosciences while Bhark previously worked in corporate development at Gilead Sciences.

Therachon takes in $60 mln

Basel, Switzerland-based Therachon, a biotechnology company focused on rare diseases, has closed $60 million in financing. Novo Holdings led the round with participation from Cowen Healthcare Investments, Pfizer Ventures, Tekla Capital Management LLC, Versant Ventures, OrbiMed, Bpifrance and Inserm Transfert Initiative.

Investor group commits $30 mln to merged OvaScience and Millendo

An investor syndicate that includes New Enterprise Associates, Frazier Healthcare Partners, Roche Venture Fund, Innobio managed by Bpifrance, Osage University Partners, Altitude Life Science Ventures, Adams Street Partners, and Longwood Fund has committed to invest $30 million in the newly merged OvaScienceSM and Millendo Therapeutics. OvaScience is a developer of treatments for women and couples struggling with infertility while Millendo Therapeutics Inc is a clinical-stage biopharmaceutical company focused on treating orphan endocrine diseases. The newly combined company is expected to operate under the name Millendo Therapeutics and trade on the NASDAQ under the ticker symbol "MLND."